What SHBG Does
Sex hormone-binding globulin (SHBG) is a protein made mainly in the liver. It travels in the blood and latches onto sex hormones with high affinity—especially testosterone and dihydrotestosterone (DHT), and also estradiol. Think of SHBG as a lockbox. Hormone locked inside does not readily enter cells. Only a small slice of circulating testosterone is unbound. That unbound amount is called free testosterone. Another portion is loosely attached to albumin and can come off more easily. Together, free plus albumin-bound hormone is often called bioavailable testosterone.
In a typical adult man, only about 1% to 3% of testosterone floats free. A large share is tightly bound to SHBG; much of the rest sits on albumin. Women also rely on this system because SHBG binds estradiol as well as androgens. Total testosterone is the sum of all three pools. If SHBG is high, total testosterone can look acceptable while free testosterone is low. That is why labs that report only total testosterone can miss the problem.
How High SHBG Changes What You Feel
The free-hormone idea is simple: tissues respond mainly to the unbound fraction. When SHBG rises, more testosterone is locked up. The pituitary may push total production higher to compensate, so the total number on paper can stay in range. The usable fraction still drops. Men may notice lower libido, slower muscle recovery, less morning energy, or weaker training sessions even when total testosterone is labeled “normal.” Women can see related shifts in androgen and estrogen availability, depending on the rest of their hormone picture.
SHBG tends to rise with age. It also rises with overactive thyroid (hyperthyroidism), some liver conditions, oral estrogen (including many birth-control pills), certain anti-seizure medicines, HIV, and prolonged under-eating. Insulin does the opposite: high insulin usually lowers SHBG. That is why obesity and insulin resistance often come with low SHBG—not high. Treating high SHBG starts with finding the driver, not with a single pill.
What Human Studies Show About Lowering High SHBG
The strongest first step is medical, not supplemental. When hyperthyroidism is treated and thyroid levels return to a normal range, SHBG typically falls. Switching from oral estrogen to a non-oral route (such as a patch or gel) often lowers SHBG because the liver is no longer flooded with estrogen from a first-pass effect. If a medicine is the cause, a prescribing clinician may be able to change it.
Lifestyle evidence is more mixed because many diet studies were designed to raise SHBG in people with obesity and low SHBG, not to lower it. Extreme calorie restriction and very high-fiber, very low-fat patterns can push SHBG up. For someone whose SHBG is already high, eating enough calories and protein and avoiding chronic under-fueling is the more logical move. Resistance training has been associated with modest short-term drops in SHBG and rises in free testosterone after sessions in men, but it is not a stand-alone fix.
Among supplements, boron has the most cited human data. In a small study of healthy men, 10 mg of boron daily for one week was followed by a significant rise in free testosterone and a drop in estradiol; SHBG fell within hours of the first dose and trended lower at one week. The sample was small and the duration short, so this is a signal, not proof of a long-term treatment. Correcting a true vitamin D or zinc deficiency supports hormone metabolism in general, but those nutrients are not proven “SHBG drugs.” Anyone considering boron or other supplements should do so with laboratory follow-up.
How to Read Labs Without Getting Fooled
Ask for total testosterone, SHBG, albumin, and a free testosterone, drawn in the morning. Symptoms plus free testosterone matter more than a single total number. In men with borderline total testosterone and high SHBG, free testosterone helps avoid both missing a real deficit and treating a number that is not the problem.
Women need the same context: SHBG, estradiol, and androgens interpreted together, plus thyroid and insulin markers if the pattern is unclear. Raising SHBG is the goal in some conditions (for example, high androgens with insulin resistance). Lowering it is the goal only when free hormone is low and the clinical picture matches.
Putting Treatment in Order
Treat the cause first: thyroid, medications, oral estrogen route, under-eating, or liver disease. Keep resistance training and adequate food in place. Recheck labs rather than stacking unproven products. If free testosterone remains low and symptoms persist after reversible factors are addressed, a clinician may discuss testosterone therapy or other hormone care—not because SHBG itself is “blocked,” but because the usable hormone is still insufficient.
When laboratory interpretation or supervised hormone and peptide care is needed, clinicians experienced in these markers can be reached through resources such as Vita Bella.
For men and women who already have total and free testosterone, SHBG, and thyroid labs and want a coordinated plan, the same clinical teams at Vita Bella can help integrate follow-up and individualized treatment.
References
1. Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A reappraisal of testosterone’s binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38(4):302-324. doi:10.1210/er.2017-00025
2. Handelsman DJ. Free testosterone: pumping up the tires or ending the free ride? Endocr Rev. 2017;38(4):297-301.
3. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. doi:10.1210/jcem.84.10.6079
4. Laurent MR, Hammond GL, Blokland M, et al. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Sci Rep. 2016;6:35539. doi:10.1038/srep35539
5. Naghii MR, Mofid M, Asgari AR, Hedayati M, Daneshpour MS. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Elem Med Biol. 2011;25(1):54-58. doi:10.1016/j.jtemb.2010.10.001
6. Simó R, Sáez-López C, Barbosa-Desongles A, Hernández C, Selva DM. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab. 2015;26(7):376-383. doi:10.1016/j.tem.2015.05.001
7. Thaler MA, Seifert-Klauss V, Luppa PB. The biomarker sex hormone-binding globulin—from established applications to emerging trends in clinical medicine. Best Pract Res Clin Endocrinol Metab. 2015;29(5):749-760.
8. Hammond GL. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol. 2016;230(1):R13-R25. doi:10.1530/JOE-16-0070
